TAK-639 is a promising drug in the biomedical industry. Extensive research has shown that TAK-639 is effective in treating a range of autoimmune diseases, including rheumatoid arthritis and psoriasis.
CAT No: R2003
TAK-639 is a small-molecule biochemical compound recognized for its role as a potent and selective inhibitor of the bromodomain and extraterminal (BET) family of proteins. As an epigenetic modulator, it targets bromodomains that recognize acetylated lysine residues on histone tails, thereby influencing chromatin structure and gene transcription. Its specificity for BET proteins, including BRD2, BRD3, and BRD4, has made it an important tool in the investigation of transcriptional regulation, cellular differentiation, and signal transduction pathways. The compound's well-characterized mechanism of action and chemical stability have led to its adoption in a range of molecular biology and biochemical research contexts.
Epigenetic research: TAK-639 is widely used in studies exploring the role of bromodomain-containing proteins in chromatin remodeling and gene expression. By selectively inhibiting BET proteins, it allows researchers to dissect the contribution of these epigenetic readers to transcriptional regulation. This functional blockade provides valuable insights into the dynamic interplay between histone modifications and gene activation or repression, facilitating the identification of key regulatory pathways in cellular development and disease models.
Transcriptional profiling: In transcriptomics and gene expression studies, the compound serves as a precise tool for modulating BET-dependent transcription. Researchers utilize it to induce specific changes in mRNA levels, enabling the mapping of downstream gene networks controlled by bromodomain activity. This approach is instrumental in elucidating the molecular basis of cell identity, lineage commitment, and adaptive responses to environmental cues.
Signal transduction analysis: The ability of TAK-639 to interfere with BET protein-mediated signaling cascades has established its value in the study of intracellular communication. By perturbing these pathways, investigators can examine the consequences of altered transcriptional output on cellular signaling networks, uncovering novel nodes of regulation and potential intervention points for further biochemical exploration.
Cellular differentiation studies: The compound is frequently employed in experiments designed to probe the influence of BET proteins on stem cell maintenance, lineage specification, and differentiation. Its selective inhibition supports the dissection of transcriptional programs that govern cell fate decisions, offering a controlled system to study the epigenetic control of developmental processes in vitro.
Chemical probe validation: TAK-639 is also utilized as a benchmark compound in the validation of new chemical probes targeting bromodomains. Its well-defined selectivity profile and robust activity provide a reference standard for assessing the efficacy and specificity of novel inhibitors in biochemical assays. This application is critical for advancing probe development and ensuring the reliability of high-throughput screening campaigns focused on epigenetic targets.
2. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More